Metabolic control of patients with phenylketonuria in a portuguese metabolic centre comparing three different recommendations
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/127063 |
Resumo: | Funding Information: Conflicts of Interest: M.F.A. received grants from Glutamine, Nutricia, Merck Serono, Biomarin, Orphan and Lifediet to attend scientific meetings. A.M. has received research funding and honoraria from Nutricia, Vitaflo International and Merck Serono. She is a member of the European Nutritionist Expert Panel (Biomarin), a member of Sapropterin Advisory Board (Biomarin), a member of the advisory board entitled ELEMENT (Danone-Nutricia), and a member of an advisory board for Arla and Applied Pharma Research. A.P. received an educational grant from Cambrooke Therapeutics and grants from Vitaflo, Nutricia, Merck Serono, Biomarin, and Mevalia to attend scientific meetings. J.C.R. is a member of the European Nutritionist Expert Panel (Biomarin), the Advisory Board for Applied Pharma Research and Nutricia, and received honoraria as a speaker from APR, Merck Serono, Biomarin, Nutricia, Vitaflo, Cambrooke, PIAM and Lifediet. Funding Information: Funding: CINTESIS—UIDB/4255/2020 a program financially supported by Fundação para a Ciência e Tecnologia/Ministério da Educação e Ciência, through national funds is acknowledged. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. |
id |
RCAP_f8606dbc816498a89f3eea291a61b887 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/127063 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Metabolic control of patients with phenylketonuria in a portuguese metabolic centre comparing three different recommendationsGuidelinesMetabolic controlPhenylalaninePhenylketonuriaFood ScienceNutrition and DieteticsFunding Information: Conflicts of Interest: M.F.A. received grants from Glutamine, Nutricia, Merck Serono, Biomarin, Orphan and Lifediet to attend scientific meetings. A.M. has received research funding and honoraria from Nutricia, Vitaflo International and Merck Serono. She is a member of the European Nutritionist Expert Panel (Biomarin), a member of Sapropterin Advisory Board (Biomarin), a member of the advisory board entitled ELEMENT (Danone-Nutricia), and a member of an advisory board for Arla and Applied Pharma Research. A.P. received an educational grant from Cambrooke Therapeutics and grants from Vitaflo, Nutricia, Merck Serono, Biomarin, and Mevalia to attend scientific meetings. J.C.R. is a member of the European Nutritionist Expert Panel (Biomarin), the Advisory Board for Applied Pharma Research and Nutricia, and received honoraria as a speaker from APR, Merck Serono, Biomarin, Nutricia, Vitaflo, Cambrooke, PIAM and Lifediet. Funding Information: Funding: CINTESIS—UIDB/4255/2020 a program financially supported by Fundação para a Ciência e Tecnologia/Ministério da Educação e Ciência, through national funds is acknowledged. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.Blood phenylalanine (Phe) is used as the primary marker to evaluate metabolic control. Our study aimed to describe the metabolic control of patients with phenylketonuria (PKU) comparing three different treatment recommendations (European guidelines/US guidelines/Portuguese consensus). This was a retrospective, observational, single centre study in patients with PKU collecting data on blood Phe levels from 2017. Nutritional intake data and sapropterin (BH4) prescription were collected at the last appointment of 2017. The final sample studied included 87 patients (48% females) [13 hyperphenylalaninemia; 47 mild PKU; 27 classical PKU] with a median age of 18 y (range: 1–36 y). The median number of blood Phe measurements for patients was 21 (range: 6–89). In patients aged < 12 y, the median blood Phe level was 300 µmol/L (range 168–480) and 474 µmol/L (range 156–1194) for patients ≥ 12 y. Overall, a median of 83% of blood Phe levels were within the European PKU guidelines target range. In patients aged ≥ 12 years, there was a higher median % of blood Phe levels within the European PKU guidelines target range (≥12 y: 84% vs. <12 y: 56%). In children < 12 y with classical PKU (n = 2), only 34% of blood Phe levels were within target range for all 3 guidelines and 49% with mild PKU (n = 11). Girls had better control than boys (89% vs. 66% median Phe levels within European Guidelines). Although it is clear that 50% or more patients were unable to achieve acceptable metabolic control on current treatment options, a globally agreed upper Phe target associated with optimal outcomes for age groups is necessary. More studies need to examine how clinics with dissimilar resources, different therapeutic Phe targets and frequency of monitoring relate to metabolic control.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNKanufre, VivianeAlmeida, Manuela FerreiraBarbosa, Catarina SousaCarmona, CarlaBandeira, AnabelaMartins, EsmeraldaRocha, SaraGuimas, ArlindoRibeiro, RosaMacdonald, AnitaPinto, AlexRocha, Júlio César2021-11-03T05:03:00Z2021-092021-09-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/127063eng1422-8599PURE: 34339860https://doi.org/10.3390/nu13093118info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:07:09Zoai:run.unl.pt:10362/127063Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:46:01.195052Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Metabolic control of patients with phenylketonuria in a portuguese metabolic centre comparing three different recommendations |
title |
Metabolic control of patients with phenylketonuria in a portuguese metabolic centre comparing three different recommendations |
spellingShingle |
Metabolic control of patients with phenylketonuria in a portuguese metabolic centre comparing three different recommendations Kanufre, Viviane Guidelines Metabolic control Phenylalanine Phenylketonuria Food Science Nutrition and Dietetics |
title_short |
Metabolic control of patients with phenylketonuria in a portuguese metabolic centre comparing three different recommendations |
title_full |
Metabolic control of patients with phenylketonuria in a portuguese metabolic centre comparing three different recommendations |
title_fullStr |
Metabolic control of patients with phenylketonuria in a portuguese metabolic centre comparing three different recommendations |
title_full_unstemmed |
Metabolic control of patients with phenylketonuria in a portuguese metabolic centre comparing three different recommendations |
title_sort |
Metabolic control of patients with phenylketonuria in a portuguese metabolic centre comparing three different recommendations |
author |
Kanufre, Viviane |
author_facet |
Kanufre, Viviane Almeida, Manuela Ferreira Barbosa, Catarina Sousa Carmona, Carla Bandeira, Anabela Martins, Esmeralda Rocha, Sara Guimas, Arlindo Ribeiro, Rosa Macdonald, Anita Pinto, Alex Rocha, Júlio César |
author_role |
author |
author2 |
Almeida, Manuela Ferreira Barbosa, Catarina Sousa Carmona, Carla Bandeira, Anabela Martins, Esmeralda Rocha, Sara Guimas, Arlindo Ribeiro, Rosa Macdonald, Anita Pinto, Alex Rocha, Júlio César |
author2_role |
author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
dc.contributor.author.fl_str_mv |
Kanufre, Viviane Almeida, Manuela Ferreira Barbosa, Catarina Sousa Carmona, Carla Bandeira, Anabela Martins, Esmeralda Rocha, Sara Guimas, Arlindo Ribeiro, Rosa Macdonald, Anita Pinto, Alex Rocha, Júlio César |
dc.subject.por.fl_str_mv |
Guidelines Metabolic control Phenylalanine Phenylketonuria Food Science Nutrition and Dietetics |
topic |
Guidelines Metabolic control Phenylalanine Phenylketonuria Food Science Nutrition and Dietetics |
description |
Funding Information: Conflicts of Interest: M.F.A. received grants from Glutamine, Nutricia, Merck Serono, Biomarin, Orphan and Lifediet to attend scientific meetings. A.M. has received research funding and honoraria from Nutricia, Vitaflo International and Merck Serono. She is a member of the European Nutritionist Expert Panel (Biomarin), a member of Sapropterin Advisory Board (Biomarin), a member of the advisory board entitled ELEMENT (Danone-Nutricia), and a member of an advisory board for Arla and Applied Pharma Research. A.P. received an educational grant from Cambrooke Therapeutics and grants from Vitaflo, Nutricia, Merck Serono, Biomarin, and Mevalia to attend scientific meetings. J.C.R. is a member of the European Nutritionist Expert Panel (Biomarin), the Advisory Board for Applied Pharma Research and Nutricia, and received honoraria as a speaker from APR, Merck Serono, Biomarin, Nutricia, Vitaflo, Cambrooke, PIAM and Lifediet. Funding Information: Funding: CINTESIS—UIDB/4255/2020 a program financially supported by Fundação para a Ciência e Tecnologia/Ministério da Educação e Ciência, through national funds is acknowledged. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-11-03T05:03:00Z 2021-09 2021-09-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/127063 |
url |
http://hdl.handle.net/10362/127063 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1422-8599 PURE: 34339860 https://doi.org/10.3390/nu13093118 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138064478502912 |